MAGE-A10ᶜ⁷⁹⁶T for Urothelial Cancer, Melanoma or Head and Neck Cancers

Clinical trial NCT02989064 · COMPLETED

Trial details

NCT number: NCT02989064
Sponsor: Adaptimmune
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Urothelial Carcinoma Head and Neck Cancer Melanoma Bladder Urothelial Carcinoma

Start date: 2016-10-01
Primary completion: 2019-12-18
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.